USD10
RGC Shares
About Regencell BioscienceRegencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
USD10
RGC Shares
About Regencell BioscienceRegencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$4.75B
OPEN PRICE
$10.31
LOW (1Y)
$4.51
HIGH (1Y)
$69.00
LOW (24H)
$8.83
HIGH (24H)
$10.33
VOLUME (24H)
$732.51K
61.8%
Price history
Time | Price | Change |
|---|---|---|
Today | $10.31 | |
1 Day | $10.37 | |
1 Week | $7.30 | |
1 Month | $5.76 | |
1 Year | $16.96 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.